Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rapid Micro Biosystems (RPID) Net Cash Flow (2020 - 2025)

Rapid Micro Biosystems (RPID) has disclosed Net Cash Flow for 6 consecutive years, with $1.1 million as the latest value for Q4 2025.

  • Quarterly Net Cash Flow rose 121.46% to $1.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.0 million through Dec 2025, up 141.66% year-over-year, with the annual reading at $3.0 million for FY2025, 141.66% up from the prior year.
  • Net Cash Flow hit $1.1 million in Q4 2025 for Rapid Micro Biosystems, up from $613000.0 in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $119.5 million in Q3 2021 to a low of -$115.9 million in Q1 2022.
  • Historically, Net Cash Flow has averaged -$493250.0 across 5 years, with a median of -$1.3 million in 2024.
  • Biggest five-year swings in Net Cash Flow: surged 1430.3% in 2021 and later plummeted 1112.42% in 2024.
  • Year by year, Net Cash Flow stood at -$41.2 million in 2021, then soared by 102.99% to $1.2 million in 2022, then tumbled by 59.5% to $499000.0 in 2023, then tumbled by 1112.42% to -$5.1 million in 2024, then skyrocketed by 121.46% to $1.1 million in 2025.
  • Business Quant data shows Net Cash Flow for RPID at $1.1 million in Q4 2025, $613000.0 in Q3 2025, and -$654000.0 in Q2 2025.